Press Conference

Recent Media Coverage

Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.

Optimism Reigns Among Instrument Firms At Pittcon

Instrument firm executives at the Pittsburgh Conference on Analytical Chemistry & Applied Spectroscopy (Pittcon) this week said they want to see last year’s healthy sales pace continue into 2015.

PerkinElmer and Waters Collaborate

PerkinElmer (Massachussetts, USA) has announced that they will collaborate with Waters Corporation (Massachussetts, USA) to standardize PerkinElmer liquid chromatography (LC) and gas chromatography (GC) instrumention.

PerkinElmer Equips J&J Innovation JLABS’ Incubator

Lab solutions provider PerkinElmer Inc. announced its collaboration with Johnson & Johnson Innovation to equip its JLABS @South San Francisco (JLABS @SSF) life science incubator with instruments and lab services to address the research needs of resident startups.

PerkinElmer: Innovation for a Better Future

Operating in over 150 countries, PerkinElmer is one of the global companies listed on the S&P 500 and the Russell 3000 Indices.

Identifying risks for early onset pre-eclampsia

An interview with Morey Kraus, Chief Scientific Officer of the Diagnostics division of PerkinElmer, and Kypros Nicolaides, Professor of Fetal Medicine, King's College, London, UK.

Perkin Elmer Opens Medical Lab in Suzhou

This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults.

Protecting the food chain from food fraud

Food fraud is defined by the United Kingdom’s Food Standard Agency as date tampering or selling goods past their use-by date, packing and selling products with an unknown origin, deliberately mislabeling food like farmed salmon as being wild, or using stolen or poached animal meat.

Ligand-Binding Assays and the Determination of Biosimilarity

During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the targeted branded biologic.

The Clouds are Rolling in

Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.

PerkinElmer Acquires Perten Instruments

US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.

Collaborators Seek Biomarkers to Evaluate Patient Selection for Cancer Immunotherapy

OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.

PerkinElmer Meets 3Q Profit Forecasts

PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.

PerkinElmer Boosts Lab IT Services with Ceiba Solutions Purchase

Ceiba’s managed services, certification, and informatics technologies will be integrated into PKI’s OneSource Lab IT portfolio, which includes lab computing, scientific application and data services, and computer systems validation.

Elements: A New Approach to Collaborative Science

Take a tour through Elements as PerkinElmer demonstrates this new platform. Share research results with colleagues globally, review comments, gather input, and explore the ways in which Elements can help you with your research effectively.